| [1] |
Cheung N, Mitchell P, Wong TY. 2010. Diabetic retinopathy. |
| [2] |
Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, et al. 2023. Prevalence of diabetic retinopathy in the US in 2021. |
| [3] |
Varma R, Torres M, Peña F, Klein R, Azen SP. 2004. Prevalence of diabetic retinopathy in adult Latinos. |
| [4] |
Sun R, Feng J, Wang J. 2024. Underlying mechanisms and treatment of cellular senescence-induced biological barrier interruption and related diseases. |
| [5] |
Li Q, Wang M, Li X, Shao Y. 2023. Aging and diabetic retinopathy: inherently intertwined pathophysiological processes. |
| [6] |
Leley SP, Ciulla TA, Bhatwadekar AD. 2021. Diabetic retinopathy in the aging population: a perspective of pathogenesis and treatment. |
| [7] |
Guo Y, Yonamine S, Ma CJ, Stewart JM, Acharya N, et al. 2023. Developing and validating models to predict progression to proliferative diabetic retinopathy. |
| [8] |
Wei L, Sun X, Fan C, Li R, Zhou S, et al. 2022. The pathophysiological mechanisms underlying diabetic retinopathy. |
| [9] |
Mortuza R, Chen S, Feng B, Sen S, Chakrabarti S. 2013. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. |
| [10] |
Campisi J, d'Adda di Fagagna F. 2007. Cellular senescence: when bad things happen to good cells. |
| [11] |
Gandhi M, Haider S, Chang HZY, Kazlauskas A. 2025. The role of endothelial senescence in the pathogenesis of diabetic retinopathy. |
| [12] |
Crespo-Garcia S, Tsuruda PR, Dejda A, Ryan RD, Fournier F, et al. 2021. Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition. |
| [13] |
Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. 2015. Cellular senescence in type 2 diabetes: a therapeutic opportunity. |
| [14] |
Tang H, Luo N, Zhang X, Huang J, Yang Q, et al. 2024. Association between biological aging and diabetic retinopathy. |
| [15] |
Le Floch JP, Doucet J, Bauduceau B, Verny C, the SFD/SFGG Intergroup. 2014. Retinopathy, nephropathy, peripheral neuropathy and geriatric scale scores in elderly people with Type 2 diabetes. |
| [16] |
Gao J, Wu K, Wang X, Li Z, Liu X, et al. 2025. Study on the prevalence of diabetic retinopathy in Pudong New Area and the predictive value of estimated glucose disposal rate: a cross-sectional study. |
| [17] |
Zhang D, Li N, Li F. 2025. Advances in ocular aging: combining deep learning, imaging, and liquid biopsy biomarkers. |
| [18] |
Wei Q, Chen R, He X, Qu Y, Yan C, et al. 2024. Multi-omics and single cell characterization of cancer immunosenescence landscape. |
| [19] |
Lucas V, Cavadas C, Aveleira CA. 2023. Cellular senescence: from mechanisms to current biomarkers and senotherapies. |
| [20] |
de Magalhães JP. 2024. Cellular senescence in normal physiology. |
| [21] |
Mebratu YA, Soni S, Rosas L, Rojas M, Horowitz JC, et al. 2023. The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype. |
| [22] |
Liu X. 2014. Overstimulation can create health problems due to increases in PI3K/Akt/GSK3 insensitivity and GSK3 activity. |
| [23] |
Zhang P, Zhang N, Hu Y, Deng X, Zhu M, et al. 2025. Role of PI3K/AKT/MAOA in glucocorticoid-induced oxidative stress and associated premature senescence of the trabecular meshwork. |
| [24] |
Bosmann M, Patel VR, Russkamp NF, Pache F, Zetoune FS, et al. 2011. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. |
| [25] |
Zheng QY, Xu F, Yang Y, Sun DD, Zhong Y, et al. 2020. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells. |
| [26] |
Yoshida Y, Nishi H. 2022. The role of the complement system in kidney glomerular capillary thrombosis. |
| [27] |
Prattichizzo F, De Nigris V, Mancuso E, Spiga R, Giuliani A, et al. 2018. Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages. |
| [28] |
Xiao J, Li HS, Satyanarayanan SK, Leung SL, Yuan Q, et al. 2024. Advancements in targeting macrophage senescence for age-associated conditions. |
| [29] |
Li J, Li X, Hu J, You Z, Jing Z. 2025. Unveiling anaphylatoxins: Pioneering cancer therapies through complement system insights. |
| [30] |
Ali Gul M, Tozcu Yilmaz D, Aydin N, Tufek M, Capraz M. 2025. The role of ADAM9 and MMP9 in diabetic retinopathy: insights from ocular parameters. |
| [31] |
Oubaha M, Miloudi K, Dejda A, Guber V, Mawambo G, Sapieha P. 2016. Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy. |